3-Hour FDA Audit Preparation Virtual Seminar PowerPoint PPT Presentation

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: 3-Hour FDA Audit Preparation Virtual Seminar


1
FDA Audit, Preparation, Inspection, ConductDos
and Donts
By Speaker
Charles H. Paul, President C. H. Paul Consulting,
Inc.
2024 C. H. Paul Consulting Inc. All rights
reserved
2
Topics
  • Inspection basics
  • Types of inspections
  • Consequences of non-compliance
  • Why does the FDA inspect?
  • Who does the FDA inspect?
  • Good Manufacturing Practices
  • Who are the inspectors and how do they work.
  • Investigation reference documents
  • How to prepare for an FDA inspection
  • Quality System Inspection Readiness
  • Records and documents
  • CAPA and the FDA inspection
  • Inspection prep for CAPA
  • Data integrity
  • The inspection process
  • Personal behaviors during the inspection

3
FDA Inspections Introduction
  • The Food and Drug Administration (FDA) plays a
    pivotal role in safeguarding public health by
    regulating various sectors within the life
    sciences industries.
  • Central to its regulatory framework is the
    practice of conducting inspections.
  • Inspections serve as a crucial mechanism for
    ensuring compliance with regulatory standards and
    Good Manufacturing Practices (GMP).
  • FDA inspections are unannounced and encompass a
    comprehensive review of all aspects of
    production.
  • During inspections, FDA investigators
    meticulously evaluate facilities' adherence to
    regulations.
  • By scrutinizing critical components, the FDA aims
    to identify any deviations or deficiencies.

4
Types of Inspections
  • Pre-Approval Inspections (PAIs)
  • Post Approval Inspections
  • Routine Surveillance Inspections
  • For-Cause or Compliance Follow-Up Inspections
  • Post-Market Inspections
  • Import Inspections

5
Difference between Post Approval, Post Market,
and Surveillance Inspections
  • Post-Approval FDA Inspection Occurs after a
    product has received regulatory approval or
    clearance
  • Post-Market Inspection Conducted after a product
    has been approved or cleared for marketing
    Routine
  • Surveillance Inspection Conducted periodically
    or as needed to assess compliance with regulatory
    requirements.

6
Inspection Overview
  • Initiated without prior notice,
  • FDA inspections are conducted by trained
    investigators
  • Manufacturing facilities, laboratories, and
    processes are examined.
  • These inspections may be routine or conducted in
    response to complaints, adverse events, or
    emerging safety concerns.
  • Investigators employ a systematic approach to
    evaluate facilities' adherence to Good
    Manufacturing Practices (GMP) and other
    regulations.
  • Reviewing critical documentation such as standard
    operating procedures.
  • Investigators assess the physical infrastructure
    of facilities.

7
What Is The Difference Between Inspections?
  • Pharmaceutical inspections
  • Biotechnology inspections
  • Medical device inspections
  • Combination product inspections

8
What is a Warning Letter?
  • The issuance of a warning letter represents a
    formal notice from the FDA to the recipient that
    corrective actions are required.
  • Warning letters are considered public documents
    and are typically posted on the FDA's website for
    public access.
  • The issuance of a warning letter may have
    significant implications for the recipient,
    including reputational damage, increased
    regulatory scrutiny, and potential legal
    liabilities.

9
Why Is Sound Inspection Preparation Important?
  • Regulatory Compliance standards during
    inspections.
  • Risk Mitigation
  • Reputation Management
  • Product Quality and Safety
  • Business Continuity
  • Continuous Improvement

10
Critical Inspection Mistakes
  • Inadequate Documentation
  • Poor Record-Keeping Practices
  • Non-Compliance with GMPs/QSRs
  • Lack of Adequate Training
  • Insufficient Risk Management
  • Ineffective CAPA Processes
  • Poor Communication with FDA Inspectors
  • Failure to Implement Lessons Learned

11
Best Practices Do the right Things Right
  • Preparation
  • Have adequately trained staff with relevant
    expertise and accountability.
  • Obtain upper management support
  • Utilize and value independent regulatory
    compliance and quality assurance teams
  • Ensure the commitments made from previous
    inspections have been implemented
  • Understand your potential quality data sources so
    information can be quickly and easily sourced as
    required
  • Implement and assess an effective quality system
  • Ensure there is a designated company Inspection
    Team
  • Ensure all proper documentation and records are
    up-to-date
  • Maintain effective Management Review and CAPA
    systems.
  • Identify true root causes of issues using
    appropriate problem-solving tools.
  • Understand when a product, or quality issue is
    significant.
  • Have defined metric systems to monitor your
    quality system in order to identify trends, gaps,
    and opportunities

12
What is the Regulatory Expectation?
  • What is the implied documentation expectation?
  • That documents are complete provide all
    necessary information
  • Clear easily understood
  • Visual
  • Flawlessly written
  • Accurate - timely
  • Provide sufficient information for users to
    exactly perform the task in the case of WIs or
    exhibit the behavior in the case of other
    general/policy SOPs
  • Are consistently followed management element
  • Controlled and secure
  • Easily revised as requirements change
  • Training element

13
What is CAPA?
  • Corrective and Preventive Actions. It is a
    systematic approach used by organizations to
    identify, investigate, and address
    non-conformities, quality issues, and potential
    risks.
  • The purpose of CAPA is
  • Corrective actions focus on addressing an
    existing issue or non-conformance, aiming to
    eliminate the root cause, mitigate immediate
    risks, and restore compliance.
  • Preventive actions are proactive measures
    implemented to prevent the recurrence of similar
    issues or potential problems in the future.

14
Preparation Steps
  • Understand Regulatory Requirements
  • Review and Update CAPA Procedures
  • Conduct Internal Audits
  • Train Personnel
  • Perform Mock Inspections
  • Document and Organize CAPA Records
  • Conduct CAPA System Review
  • Stay Updated on Regulatory Changes
  • Maintain a Culture of Compliance

15
What is Data Integrity?
  • Data integrity refers to the accuracy,
    reliability, and consistency of data
  • It is a fundamental aspect of regulatory
    compliance
  • Data integrity encompasses various principles,
    practices, and controls

16
Elements of Data Integrity
  • Accuracy
  • Completeness
  • Consistency
  • Validity
  • Timeliness
  • Security
  • Traceability

17
Common Data Integrity Violations
  • Failure to maintain complete data derived from
    all laboratory tests conducted to ensure
    compliance with established API specifications
    and standards
  • Failure to prevent unauthorized access or changes
    to data, and failure to provide adequate controls
    to prevent omission of data
  • Failure to record activities at the time they are
    performed and destruction of original records.
  • Failure to train employees on their particular
    operations and related GMP practices.

18
Common Data Integrity Errors
  • Incomplete Data
  • Data Falsification
  • Data Entry Errors
  • Data Overwriting
  • Data Duplication
  • Data Loss or Corruption
  • Lack of Data Traceability
  • Non-Compliant Electronic Records
  • Poor Data Management Practices
  • Insufficient Training and Oversight

19
Documents that Cannot be Reviewed
  • Audit reports
  • Financial records and documents
  • Research data/protocols
  • Personnel records
  • Management meeting minutes

20
Exit Process
  • Inspector will present a written FDA form (FDA
    483) if necessary
  • Company should take extensive notes and make sure
    everyone understands the issues
  • Any response to a 483 observation by the company
    should be brief
  • If issue remains unresolved, request that the
    inspector annotate the FDA 483
  • Note any corrective actions

21
Post Inspection
  • Date of inspection
  • Inspection team members
  • Reasons for response
  • Response to each cited deficiency
  • Description of preventive and corrective action
  • Items still in dispute

22
The Psychology Of Behavior And Communications
  • Trust and Rapport Building
  • Perception and Interpretation
  • Active Listening
  • Emotional Intelligence
  • Assertiveness and Advocacy
  • Conflict Resolution
  • Cultural Sensitivity and Diversity
  • Posture and Nonverbal Communication

23
Behaviors That Must Be Exhibited
  • Professionalism
  • Cooperation
  • Transparency
  • Documentation
  • Attention to Detail
  • Compliance Mindset
  • Timeliness
  • Positive Attitude

24
Doing The Right Thing
  • Always be professional
  • Be dressed properly neat and clean
  • Follow all company cleanliness, movement, and
    dressing requirements
  • Be courteous and polite at all times
  • Correct all errors and miscommunications when
    discovered as soon as possible

25
Doing The Right Things
  • When providing documents do so in a timely manner
  • Have documents available
  • Limit the inspectors access
  • Always review the requested record before
    providing
  • Check that the record is the one asked for
  • Send only the record

26
Dealing With Difficult Inspections and Inspectors
  • Remain Calm and Composed
  • Listen Attentively
  • Clarify Misunderstandings
  • Redirect to Procedure
  • Seek Resolution
  • Invoke Chain of Command
  • Document Interactions
  • Follow Up Appropriately

27
Questions
2024 C. H. Paul Consulting Inc. All rights
reserved
Write a Comment
User Comments (0)
About PowerShow.com